A Singapore-based team at Duke-NUS Medical School have spent the last year working on a COVID-19 vaccine. How close are they to producing one and will it help end the pandemic?

Duke-NUS Medical School in Singapore and San Diego-based Arcturus Therapeutics have partnered to develop a COVID-19 vaccine. It is a self-replicating mRNA vaccine. So while the mRNA technology is similar to vaccines from Pfizer-BioNTech and Moderna, this vaccine requires a lower dose.

From pre-clinical trial to animal testing and finally to human trials, follow the whole process of vaccine development to see how COVID-19 vaccines are being produced at record speeds. Meet the scientists on the frontlines of the war against the deadly coronavirus that has claimed millions of lives around the world.

Continue watching The Vaccine Quest: https://youtu.be/G1SBc5T5npI

=========
About The Vaccine Quest: The development of vaccines for COVID-19 continues worldwide, including here at Duke-NUS. We follow the team of doctors and researchers and showcase the work that will save the lives of millions.
================
#CNAInsider #TheVaccineQuestCNA #COVID19Vaccine #LunarCov19


For more, SUBSCRIBE to CNA INSIDER!
https://cna.asia/insideryoutubesub

Follow CNA INSIDER on:
Instagram: https://www.instagram.com/cnainsider/
Facebook: https://www.facebook.com/cnainsider/
Website: https://cna.asia/cnainsider